Home › Funds › ARIEL INVESTMENTS, LLC › BIO

ARIEL INVESTMENTS, LLC position in BIO

BIO RAD LABS INC · Industrials

ARIEL INVESTMENTS, LLC reported holding 789,341 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$298.1M, representing 3.10% of its reported portfolio and ranking #7 among its reported holdings. ARIEL INVESTMENTS, LLC has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)789.34K sh
Reported value held$298.14M
Portfolio Weight3.10%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ARIEL INVESTMENTS, LLC's BIO position evolved

ARIEL INVESTMENTS, LLC first disclosed a stake in BIO in Q3 2023 at 4,529 shares (US$1.6M). The position peaked in Q3 2026 at 789,341 shares, worth US$298.1M. Across 13 filings, ARIEL INVESTMENTS, LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 789,341 shares valued at US$298.1M — a reduction of -27,410 shares quarter over quarter.. Notable position changes include a 1354% increase in Q1 2024 (shares fell 21% over the following quarter), a 60% increase in Q2 2024 (shares rose 23% over the following quarter), a 263% increase in Q3 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.53K $1.62M New
Q4 2023 4.48K $1.45M Reduce
Q1 2024 65.09K $22.51M Add
Q2 2024 104.19K $28.45M Add
Q3 2024 378.69K $126.70M Add
Q4 2024 560.52K $184.14M Add
Q1 2025 724.66K $176.50M Add
Q2 2025 818.62K $197.55M Add
Q3 2025 809.48K $226.97M Reduce
Q4 2025 764.67K $231.69M Reduce
Q1 2026 785.96K $219.09M Add
Q2 2026 816.75K $239.81M Add
Q3 2026 789.34K $298.14M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC) is a Industrials company. 24 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), EARNEST PARTNERS LLC (US$214.5M), First Pacific Advisors, LP (US$101.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has ARIEL INVESTMENTS, LLC held BIO?

ARIEL INVESTMENTS, LLC has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARIEL INVESTMENTS, LLC's current position in BIO?

As of Q3 2026, ARIEL INVESTMENTS, LLC holds 789.34K shares of BIO (BIO RAD LABS INC), valued at $298.14M, representing 3.10% of its reported portfolio and ranking #7.

Has ARIEL INVESTMENTS, LLC been buying or selling BIO?

In the latest 13F filing (Q3 2026), ARIEL INVESTMENTS, LLC reduced its position in BIO. The position peaked in Q3 2026 at 789.34K shares.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, EARNEST PARTNERS LLC, First Pacific Advisors, LP, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.